Увійти

Готові списки джерел за темами / Antibodies / Статті в журналах

Щоб переглянути інші типи публікацій з цієї теми, перейдіть за посиланням: Antibodies.

Статті в журналах з теми "Antibodies"

Автор: Grafiati

Опубліковано: 4 червня 2021

Оновлено: 25 липня 2025

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Antibodies".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.

1

Deora, Kanika, and Ruchee Khanna. "Clinical Profile of the Patients with Antiphospholipid Antibodies: Lupus Anticoagulant and Anticardiolipin Antibodies." Indian Journal of Forensic Medicine and Pathology 12, no. 3 (2019): 195–99. http://dx.doi.org/10.21088/ijfmp.0974.3383.12319.6.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Chiswell, David J., and John McCaffery. "Phage antibodies: will new ‘coliclonal’ antibodies replace monoclonal antibodies?" Trends in Biotechnology 10 (1992): 80–84. http://dx.doi.org/10.1016/0167-7799(92)90178-x.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Pooja, Tiwari Patel Pratixa Mishra Satyam Yadav Rubi. "An Extensive Review Study Of Solely Cloned Identical Antibodies - Monoclonal Antibodies." International Journal in Pharmaceutical Sciences 1, no. 12 (2023): 21–34. https://doi.org/10.5281/zenodo.10251264.

Повний текст джерела

Анотація:

Since they were developed, monoclonal antibodies have been studied for potential therapeutic use. The forefront of modern medicine's move towards a new era of individualized therapy is the use of monoclonal antibodies to treat a range of ailments. Monoclonal antibodies can be employed for therapeutic, imaging, and diagnostic applications and have a very high clinical significance. Monoclonal antibodies have a variety of intriguing potential clinical uses. Because the monoclonal antibodies used were either produced in mice or rats, there is currently a risk of disease transfer from mice to peop

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Linhardt, Robert J., C. W. Abell, R. M. Denney, et al. "Monoclonal antibodies and immobilized antibodies." Applied Biochemistry and Biotechnology 15, no. 1 (1987): 53–80. http://dx.doi.org/10.1007/bf02798506.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Favoreel, Herman W., Geert Van Minnebruggen, Gerlinde R. Van de Walle, Jolanta Ficinska, and Hans J. Nauwynck. "Herpesvirus interference with virus-specific antibodies: Bridging antibodies, internalizing antibodies, and hiding from antibodies." Veterinary Microbiology 113, no. 3-4 (2006): 257–63. http://dx.doi.org/10.1016/j.vetmic.2005.11.003.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Clark, A. "Antibodies." Journal of Clinical Pathology 42, no. 5 (1989): 559. http://dx.doi.org/10.1136/jcp.42.5.559-c.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Bradbury, Andrew, Nileena Velappan, Vittorio Verzillo, et al. "Antibodies in proteomics I: generating antibodies." Trends in Biotechnology 21, no. 6 (2003): 275–81. http://dx.doi.org/10.1016/s0167-7799(03)00112-4.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Kounis, Nicholas G., George D. Soufras, and George N. Kounis. "Antibodies against antibodies inducing Kounis syndrome." International Journal of Cardiology 168, no. 5 (2013): 4804–5. http://dx.doi.org/10.1016/j.ijcard.2013.07.037.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Trier, Nicole, Paul Hansen, and Gunnar Houen. "Peptides, Antibodies, Peptide Antibodies and More." International Journal of Molecular Sciences 20, no. 24 (2019): 6289. http://dx.doi.org/10.3390/ijms20246289.

Повний текст джерела

Анотація:

The applications of peptides and antibodies to multiple targets have emerged as powerful tools in research, diagnostics, vaccine development, and therapeutics. Antibodies are unique since they, in theory, can be directed to any desired target, which illustrates their versatile nature and broad spectrum of use as illustrated by numerous applications of peptide antibodies. In recent years, due to the inherent limitations such as size and physical properties of antibodies, it has been attempted to generate new molecular compounds with equally high specificity and affinity, albeit with relatively

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Matraszek, Veronika Viktoria, Hynek Heřman, and Ilona Hromadníková. "The relevance of antiphospholipid antibodies in obstetrics." Česká gynekologie 89, no. 3 (2024): 237–44. http://dx.doi.org/10.48095/cccg2024237.

Повний текст джерела

Анотація:

Summary: Aim and methodology: To provide a comprehensive review on new findings and current recommendations regarding antiphospholipid antibodies with particular emphasis on clinical impact on gestation. Conclusion: Antiphospholipid antibodies are an important risk factor for the development of a series of pregnancy-related complications. Early diagnosis and appropriate therapy can reduce the incidence of pregnancy loss and pregnancy-related complications. Key words: antiphospholipid antibodies – antiphospholipid syndrome – lupus anticoagulant – anticardiolipin antibodies – anti-ß2-glycoprotei

Стилі APA, Harvard, Vancouver, ISO та ін.

11

Qian, J., Y. Xing, D. Yufang, et al. "OP0216 THE CLINICAL AND PATHOLOGICAL ROLES OF AUTOANTIBODIES TARGETING BMP SIGNALING IN SYSTEMIC LUPUS ERYTHEMATOSUS-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION." Annals of the Rheumatic Diseases 82, Suppl 1 (2023): 141.1–142. http://dx.doi.org/10.1136/annrheumdis-2023-eular.3682.

Повний текст джерела

Анотація:

BackgroundPulmonary arterial hypertension (PAH) is one of the most severe complications and the leading cause of death in patients with systemic lupus erythematosus (SLE). Pathogenic mechanisms leading to SLE-PAH are still not fully understood. In idiopathic PAH, the dysfunction of the bone morphogenetic protein (BMP) pathway was found to be involved in pulmonary artery remodeling [1]. In SLE-PAH, our previous study identified serum autoantibodies targeting BMP receptors (BMPR) as the potential biomarker, including anti-BMPR2, BMPR1A, and Activin Receptor-Like Kinase type 1 (ALK1) antibodies [

Стилі APA, Harvard, Vancouver, ISO та ін.

12

Khan, Ramsha, Melissa Menard, Chao-Ching Jen, Xi Chen, Peter A. A. Norris, and Alan H. Lazarus. "Inhibition of platelet phagocytosis as an in vitro predictor for therapeutic potential of RBC antibodies in murine ITP." Blood 135, no. 26 (2020): 2420–24. http://dx.doi.org/10.1182/blood.2019003646.

Повний текст джерела

Анотація:

Abstract Polyclonal anti-D is a first-line therapy for immune thrombocytopenia (ITP). Monoclonal antibodies are desirable alternatives, but none have yet proven successful despite their ability to opsonize erythrocytes (or red blood cells, RBCs) and cause anemia. Here, we examined 12 murine erythrocyte–specific antibodies of different specificity and subtypes and found that 8 of these antibodies could induce anemia in antigen-positive mice. Of these 8 antibodies, only 5 ameliorated ITP. All antibodies were examined for their in vitro ability to support macrophage-mediated phagocytosis of eryth

Стилі APA, Harvard, Vancouver, ISO та ін.

13

Reddy, Raghuram, Joel Mintz, Roei Golan, et al. "Antibody Diversity in Cancer: Translational Implications and Beyond." Vaccines 10, no. 8 (2022): 1165. http://dx.doi.org/10.3390/vaccines10081165.

Повний текст джерела

Анотація:

Patients with cancer tend to develop antibodies to autologous proteins. This phenomenon has been observed across multiple cancer types, including bladder, lung, colon, prostate, and melanoma. These antibodies potentially arise due to induced inflammation or an increase in self-antigens. Studies focusing on antibody diversity are particularly attractive for their diagnostic value considering antibodies are present at an early diseased stage, serum samples are relatively easy to obtain, and the prevalence of antibodies is high even when the target antigen is minimally expressed. Conversely, the

Стилі APA, Harvard, Vancouver, ISO та ін.

14

Rathod, PG1* Singh VK1 and Parasana DK2. "Immunochemical techniques: An Overview." Science World a monthly e magazine 2, no. 12 (2022): 2024–31. https://doi.org/10.5281/zenodo.7414424.

Повний текст джерела

Анотація:

Immunochemical techniques are based on a reaction of antigen with antibody, or more exactly, on a reaction of an antigenic determinants with the binding site of the antibody. The antibodies used are produced by various ways. Monoclonal antibodies are products of a single clone of plasma cells derived from B-lymphocytes, prepared in the laboratory by hybridoma technology, based on cellular fusion of tumor (myeloma) cells with splenic lymphocytes of immunized mice. Monoclonal antibodies are directed against single epitope; and are all identical copies of immunoglobulin molecule with the same pri

Стилі APA, Harvard, Vancouver, ISO та ін.

15

Shoenfeld, Yehuda. "The idiotypic network in autoimmunity: antibodies that bind antibodies that bind antibodies." Nature Medicine 10, no. 1 (2004): 17–18. http://dx.doi.org/10.1038/nm0104-17.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

16

Bobrovnik, S. A., M. O. Demchenko, and S. V. Komisarenko. "Effect of trifluoroethanol on antibodies binding properties." Ukrainian Biochemical Journal 95, no. 1 (2023): 20–30. http://dx.doi.org/10.15407/ubj95.01.020.

Повний текст джерела

Анотація:

The studies on the influence of organic co-solvents on the structure and function of antibodies are of key interest, especially in view of antibodies broad use as recognizing elements in different analytical systems. Here we studied the effect of co-solvent 2,2,2-trifluoroethanol (TFE) on the ability of anti-ovalbumin monoclonal antibodies to interact with its specific antigen. Antibody affinity to antigen and the rate constants of antibody binding to immobilized antigen were analyzed. Changes in antibody reactivity with incubation time which depended on TFE concentration and temperature were

Стилі APA, Harvard, Vancouver, ISO та ін.

17

Dahl, Mark V., and Alina G. Bridges. "Intravenous immune globulin: Fighting antibodies with antibodies." Journal of the American Academy of Dermatology 45, no. 5 (2001): 775–83. http://dx.doi.org/10.1067/mjd.2001.119085.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

18

SHITARA, Kenya. "Potelligent Antibodies as Next Generation Therapeutic Antibodies." YAKUGAKU ZASSHI 129, no. 1 (2009): 3–9. http://dx.doi.org/10.1248/yakushi.129.3.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

19

Methe, H. "Antibodies Stop Secretion of Antibodies in Lupus." Science Translational Medicine 4, no. 141 (2012): 141ec115. http://dx.doi.org/10.1126/scitranslmed.3004529.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

20

Filatova, Elena A., Grigory B. Krapivinsky, Grigory N. Filatov, Alisa V. Lazareva, and Evgeny E. Fesenko. "Antiidiotypic antibodies against anti-cGMP polyclonal antibodies." Biochimica et Biophysica Acta (BBA) - Biomembranes 1064, no. 2 (1991): 293–96. http://dx.doi.org/10.1016/0005-2736(91)90314-x.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

21

Nikita, Sapkal Ritesh Rathod* Sakshi Lande Pallavi Radal Haridas Khose. "Monoclonal Antibodies: Insight Review." International Journal of Pharmaceutical Sciences 2, no. 12 (2024): 249–64. https://doi.org/10.5281/zenodo.14265260.

Повний текст джерела

Анотація:

Monoclonal antibodies (mAbs) are a significant achievement in biotechnology and medicine. Kohler and Milstein's Nobel Prize-winning research on murine hybridoma technology in 1975 resulted in the development of mAbs, which are designed to function as substitute antibodies that can restore, augment, or mimic the immune system's attack on cancer cells and other infections. In 1986, the FDA approved the first monoclonal antibody, Orthoclone OKT3® (muromonab-CD3), a huge step forward in antibody research and development. Monoclonal antibodies are glycoproteins produced by identical B cell clon

Стилі APA, Harvard, Vancouver, ISO та ін.

22

Heng, Boon Chin, Wenjin Huang, Xiufang Zhong, Ping Yin, and Guo Qing Tong. "Roles of Antiphospholipid Antibodies, Antithyroid Antibodies and Antisperm Antibodies in Female Reproductive Health." Integrative Medicine International 2, no. 1-2 (2015): 21–31. http://dx.doi.org/10.1159/000381900.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

23

BYGREN, P., N. RASMUSSEN, B. ISAKSSON, and J. WIESLANDER. "Anti-neutrophil cytoplasm antibodies, anti-GBM antibodies and anti-dsDNA antibodies in glomerulonephritis." European Journal of Clinical Investigation 22, no. 12 (1992): 783–92. http://dx.doi.org/10.1111/j.1365-2362.1992.tb01447.x.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

24

Van de Perre, Philippe, Penny L. Moore, Nicolas Nagot, Lucio Gama, and Jean-Pierre Moles. "Broadly neutralizing antibodies, nonneutralizing antibodies and broadly effector antibodies to prevent HIV transmission?" AIDS 39, no. 7 (2025): 918–20. https://doi.org/10.1097/qad.0000000000004115.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

25

Kapustianenko, L. G. "POLYCLONAL ANTIBODIES AGAINST HUMAN PLASMINOGEN KRINGLE 5." Biotechnologia Acta 10, no. 3 (2017): 41–49. http://dx.doi.org/10.15407/biotech10.03.041.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

26

Yatsenko, T. A. "POLYCLONAL ANTIBODIES AGAINST HUMAN PLASMINOGEN: PURIFICATION, CHARACTERIZATION AND APPLICATION." Biotechnologia Acta 13, no. 6 (2020): 50–57. http://dx.doi.org/10.15407/biotech13.06.050.

Повний текст джерела

Анотація:

The plasminogen/plasmin system plays a crucial role in fibrinolysis and regulation of cell functions in a wide range of normal and pathological processes. Investigation of plasminogen/plasmin functions requires the availability of well-characterized and effective molecular tools, such as antibodies. In the present work, the isolation and characterization of rabbit polyclonal antibodies against human plasminogen are described and approaches for the identification of plasminogen and its fragments using the purified antibodies are demonstrated. For the antibodies isolation, standard animal immuni

Стилі APA, Harvard, Vancouver, ISO та ін.

27

Triplett, Douglas A. "Antiphospholipid Antibodies." Archives of Pathology & Laboratory Medicine 126, no. 11 (2002): 1424–29. http://dx.doi.org/10.5858/2002-126-1424-aa.

Повний текст джерела

Анотація:

Abstract Objective.—To review the role of lupus anticoagulants in the pathogenesis of both venous and arterial thromboembolic events, as well as in recurrent spontaneous abortions. The pathophysiology of lupus anticoagulants and associated antiphospholipid antibodies (eg, anticardiolipin antibodies) is also discussed. Data Sources.—Review of the recent medical literature. Data Extraction and Synthesis.—Key articles in the recent medical literature dealing with lupus anticoagulants and their role in pathogenesis of thromboembolic events were reviewed. Plasma proteins that have an affinity for b

Стилі APA, Harvard, Vancouver, ISO та ін.

28

Brinkmann, Ulrich, and Roland E. Kontermann. "Bispecific antibodies." Science 372, no. 6545 (2021): 916–17. http://dx.doi.org/10.1126/science.abg1209.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

29

Rieger, Paula Trahan. "Monoclonal Antibodies." American Journal of Nursing 87, no. 4 (1987): 469. http://dx.doi.org/10.2307/3470440.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

30

Groner, Bernd, Cord Hartmann, and Winfried Wels. "Therapeutic Antibodies." Current Molecular Medicine 4, no. 5 (2004): 539–47. http://dx.doi.org/10.2174/1566524043360483.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

31

Kosmas, C., H. Kalofonos, and A. A. Epenetos. "Monoclonal Antibodies." Drugs 38, no. 5 (1989): 645–57. http://dx.doi.org/10.2165/00003495-198938050-00001.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

32

Larrick, James W., and Kirk E. Fry. "Recombinant antibodies." Human Antibodies 2, no. 4 (1991): 172–89. http://dx.doi.org/10.3233/hab-1991-2401.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

33

Bronson, Richard A. "Sperm Antibodies." Immunology and Allergy Clinics of North America 10, no. 1 (1990): 165–84. http://dx.doi.org/10.1016/s0889-8561(22)00256-9.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

34

Pisetsky, David S. "ANTINUCLEAR ANTIBODIES." Immunology and Allergy Clinics of North America 14, no. 2 (1994): 371–85. http://dx.doi.org/10.1016/s0889-8561(22)00780-9.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

35

Smith, J. Bruce, and F. Susan Cowchock. "ANTIPHOSPHOLIPID ANTIBODIES." Immunology and Allergy Clinics of North America 14, no. 4 (1994): 821–34. http://dx.doi.org/10.1016/s0889-8561(22)00345-9.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

36

Pratt, Donna E. "THYROID ANTIBODIES." Immunology and Allergy Clinics of North America 14, no. 4 (1994): 835–38. http://dx.doi.org/10.1016/s0889-8561(22)00346-0.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

37

Visan, Ioana. "Enhancing antibodies." Nature Immunology 22, no. 7 (2021): 800. http://dx.doi.org/10.1038/s41590-021-00973-7.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

38

Khamashta, Munther A., and Graham R. V. Hughes. "Antiphospholipid antibodies." Clinical Reviews in Allergy 12, no. 3 (1994): 287–96. http://dx.doi.org/10.1007/bf02802323.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

39

Adair, J., and A. Lawson. "Therapeutic Antibodies." Drug Design Reviews - Online 2, no. 3 (2005): 209–17. http://dx.doi.org/10.2174/1567269053828800.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

40

Pullen, Richard L. "Antinuclear antibodies." Nursing Made Incredibly Easy! 20, no. 6 (2022): 47–48. http://dx.doi.org/10.1097/01.nme.0000884112.83689.31.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

41

Santos-Argumedo, Leopoldo. "Natural Antibodies." Advances in Neuroimmune Biology 3, no. 3,4 (2012): 345–52. http://dx.doi.org/10.3233/nib-012912.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

42

&NA;. "Monoclonal antibodies." Reactions Weekly &NA;, no. 1293 (2010): 36. http://dx.doi.org/10.2165/00128415-201012930-00100.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

43

Hudson, Peter J., and Christelle Souriau. "Engineered antibodies." Nature Medicine 9, no. 1 (2003): 129–34. http://dx.doi.org/10.1038/nm0103-129.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

44

Benkovic, Stephen J. "Catalytic Antibodies." Annual Review of Biochemistry 61, no. 1 (1992): 29–54. http://dx.doi.org/10.1146/annurev.bi.61.070192.000333.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

45

Harris, E. Nigel. "ANTIPHOSPHOLIPID ANTIBODIES." British Journal of Haematology 74, no. 1 (2008): 1–9. http://dx.doi.org/10.1111/j.1365-2141.1988.00491.x-i1.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

46

Harris, E. Nigel. "ANTIPHOSPHOLIPID ANTIBODIES." British Journal of Haematology 74, no. 1 (1990): 1–9. http://dx.doi.org/10.1111/j.1365-2141.1990.tb02530.x.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

47

Drlicek, M., U. Liszka, W. Grisold, A. Mohn-Staudner, F. Lintner, and K. Jellinger. "Antineuronal antibodies." Neurology 40, no. 11 (1990): 1804. http://dx.doi.org/10.1212/wnl.40.11.1804-b.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

48

Helmerhorst, F. M., M. J. J. Finken, and J. J. Erwich. "Antisperm antibodies." Human Reproduction 14, no. 7 (1999): 1669–71. http://dx.doi.org/10.1093/humrep/14.7.1669.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

49

Worland, PhD, Peter J., Gary S. Gray, PhD, Mark Rolfe, PhD, Karen Gray, PhD, and Jeffrey S. Ross, MD. "Anticancer Antibodies." American Journal of Clinical Pathology 119, no. 4 (2003): 472–85. http://dx.doi.org/10.1309/y6lp-c0lr-726l-9dx9.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

50

Ross, Jeffrey S., Karen Gray, Gary S. Gray, Peter J. Worland, and Mark Rolfe. "Anticancer Antibodies." American Journal of Clinical Pathology 119, no. 4 (2003): 472–85. http://dx.doi.org/10.1309/y6lpc0lr726l9dx9.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!